Product Information
PIMOZIDE 2 MG TABLET is a generic product labeled by Endo USA Inc., priced at $1.6947 per EA under NDC 49884034801. Its NADAC has been published 332 times since May 18, 2016.
Strength
2 mg/1
Manufacturer
Endo USA Inc.NDC
49884034801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PIMOZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204521On Market Since
9/28/2015
Pharmacological Classes
Price Statistics
The NADAC for PIMOZIDE 2 MG TABLET has been published 332 times since May 18, 2016, and over the history we have for it it has declined 8.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6947 per EA |
|---|---|
| All-time high | $2.0100 (Sep 14, 2016) |
| All-time low | $1.4222 (May 22, 2024) |
| 52-week high | $1.7135 |
| 52-week low | $1.6758 |
| Median price | $1.7425 |
| Average price | $1.7549 |
| Largest weekly change | -17.4% (May 22, 2024) |
| Weeks tracked | 332 |
| Tracking since | May 18, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Pimozide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PIMOZIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIMOZIDE 2 MG TABLET, manufactured by Endo USA Inc., is $1.6947 per EA (NDC 49884034801), effective Jun 24, 2026.
How has the price of PIMOZIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIMOZIDE 2 MG TABLET has declined 8.3%. It has been tracked across 332 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for PIMOZIDE 2 MG TABLET?
Since May 18, 2016, the NADAC for PIMOZIDE 2 MG TABLET has ranged from a low of $1.4222 (May 22, 2024) to a high of $2.0100 (Sep 14, 2016), with a median of $1.7425 per EA.
Are there cheaper alternatives to PIMOZIDE 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PIMOZIDE 2 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PIMOZIDE 2 MG TABLET?
PIMOZIDE 2 MG TABLET (NDC 49884034801) is labeled by Endo USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification